Full fusion competence rescue of the enfuvirtide resistant HIV-1 gp41 genotype (43D) by a prevalent polymorphism (137K)

This publication has 14 references indexed in Scilit:

• Role of the Envelope Genetic Context in the Development of Enfuvirtide Resistance in Human Immunodeficiency Virus Type 1-Infected Patients
  Journal of Virology, 2006
• Characterization of Envelope Glycoprotein gp41 Genotype and Phenotypic Susceptibility to Enfuvirtide at Baseline and on Treatment in the Phase III Clinical Trials TORO-1 and TORO-2
  AIDS Research and Human Retroviruses, 2006
• Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1
  Journal of Medical Virology, 2005
• Genotype and Phenotype Patterns of Human Immunodeficiency Virus Type 1 Resistance to Enfuvirtide during Long-Term Treatment
  Antimicrobial Agents and Chemotherapy, 2004
• Role of Baseline pol Genotype in HIV-1 Fitness Evolution
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
• Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
  New England Journal of Medicine, 2003
• Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy
  Antimicrobial Agents and Chemotherapy, 2002
• Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable Viremia
  New England Journal of Medicine, 2001
• Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
  Nature Medicine, 1998
• Core Structure of gp41 from the HIV Envelope Glycoprotein
  Published by Elsevier ,1997